Tehran University of Medical Sciences

Science Communicator Platform

Share By
Convalescent Plasma Therapy for Covid-19: Lessons From Sars-Cov, Mers-Cov, and H1n1 Infection Pubmed



Hosseini P1 ; Rahimi H2 ; Najafabadi MM3 ; Ghorbani A4, 10 ; Najafabadi SK5 ; Faridzadeh A6, 11 ; Arabpour J7 ; Khormali E8 ; Deravi N9
Authors

Source: Acta Medica Indonesiana Published:2021


Abstract

The global widespread mortality after the emergence of SARS-CoV-2 infection in China, has become a critical concern all around the world. Convalescent plasma (CP) therapy is one of the methods elevating the survival rate for COVID-19 infection cases. This technique, as a practicable therapy, was used in previous viral outbreaks including influenza, SARS and MERS. In CP therapy, the blood plasma is collected from persons rehabilitated from that specific infection in order to develop a passive immunity in other patients. Therefore, this review aimed to point out the role of CP therapy in aforementioned viral infections and illustrate different factors influencing the efficacy of CP therapy. © 2021, Indonesian Society of Internal Medicine. All rights reserved.
Other Related Docs
4. Variable Clinical Manifestations of Covid-19: Viral and Human Genomes Talk, Iranian Journal of Allergy# Asthma and Immunology (2020)
6. Potential Role of Interferons in Treating Covid-19 Patients, International Immunopharmacology (2021)
9. Modern Diagnostics Processes Among New Strains of Coronaviruses: A Review, Journal of Datta Meghe Institute of Medical Sciences University (2022)
11. Covid-19: A Review on Treatment Strategies and Candidate Vaccines, Scientific Journal of Kurdistan University of Medical Sciences (2021)